TGen in the US has signed a licensing agreement with Advanced Biological Laboratories (ABL) to market its tuberculosis (TB) test technology.
The Translational Genomics Research Institute (TGen) in the US has signed a licensing agreement with integrated diagnostics firm Advanced Biological Laboratories (ABL) to market its tuberculosis (TB) test technology.

















